Polymyxin B Conjugates with Bio-Inspired Synthetic Polymers of Different Nature
Open Access
- 17 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1832
Abstract
The emergence and growth of bacterial resistance to antibiotics poses an enormous threat to humanity in the future. In this regard, the discovery of new antibiotics and the improvement of existing ones is a priority task. In this study, we proposed the synthesis of new polymeric conjugates of polymyxin B, which is a clinically approved but limited-use peptide antibiotic. In particular, three carboxylate-bearing polymers and one synthetic glycopolymer were selected for conjugation with polymyxin B (PMX B), namely, poly(α,L-glutamic acid) (PGlu), copolymer of L-glutamic acid and L-phenylalanine (P(Glu-co-Phe)), copolymer of N-vinyl succinamic acid and N-vinylsuccinimide (P(VSAA-co-VSI)), and poly(2-deoxy-2-methacrylamido-D-glucose) (PMAG). Unlike PGlu and PMAG, P(Glu-co-Phe) and P(VSAA-co-VSI) are amphiphilic and form nanoparticles in aqueous media. A number of conjugates with different polymyxin B loading were synthesized and characterized. In addition, the complex conjugates of PGLu or PMAG with polymyxin B and deferoxamine (siderophore) were obtained. A release of PMX B from Schiff base and amide-linked polymer conjugates was studied in model buffer media with pH 7.4 and 5.8. In both cases, a more pronounced release was observed under slightly acidic conditions. The cytotoxicity of free polymers and PMX B as well as their conjugates was examined in human embryonic kidney cells (HEK 293T cell line). All conjugates demonstrated reduced cytotoxicity compared to the free antibiotic. Finally, the antimicrobial efficacy of the conjugates against Pseudomonas aeruginosa was determined and compared. The lowest values of minimum inhibitory concentrations (MIC) were observed for polymyxin B and polymyxin B/deferoxamine conjugated with PMAG. Among the polymers tested, PMAG appears to be the most promising carrier for delivery of PMX B in conjugated form due to the good preservation of the antimicrobial properties of PMX B and the ability of controlled drug release.Keywords
Funding Information
- Russian Science Foundation (19-73-20157)
This publication has 40 references indexed in Scilit:
- Dextrin–Colistin Conjugates as a Model Bioresponsive Treatment for Multidrug Resistant Bacterial InfectionsMolecular Pharmaceutics, 2014
- Extracellular Acidosis Is a Novel Danger Signal Alerting Innate Immunity via the NLRP3 InflammasomeJournal of Biological Chemistry, 2013
- Synthesis and antibacterial activity of conjugates between norfloxacin and analogues of the siderophore vanchrobactinBioorganic & Medicinal Chemistry, 2013
- Antimicrobial activity and cellular toxicity of nanoparticle–polymyxin B conjugatesNanotechnology, 2011
- Schiff bases derived from p-aminobenzyl alcohol as trigger groups for pH-dependent prodrug activationTetrahedron Letters, 2010
- Cellular uptake and toxicity of microparticles in a perspective of polymyxin B oral administrationInternational Journal of Pharmaceutics, 2010
- Synthesis of Multifunctional Polyvinylsaccharide Containing Controllable Amounts of Biospecific LigandsBioconjugate Chemistry, 2008
- Water‐soluble aldehyde‐bearing polymers of 2‐deoxy‐2‐methacrylamido‐D‐glucose for bone tissue engineeringJournal of Applied Polymer Science, 2008
- Alginate microparticles for Polymyxin B Peyer's patches uptake: microparticles for antibiotic oral administrationJournal of Microencapsulation, 2004
- Stability of Schiff bases of amino acids and pyridoxal-5?-phosphateAmino Acids, 1992